USD 71.21
(-0.54%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -1.11 Billion USD | 64.51% |
2022 | 19.83 Billion USD | -964.74% |
2021 | 18.03 Billion USD | 105.0% |
2020 | -1.71 Billion USD | -236.46% |
2019 | 11.71 Billion USD | -11.08% |
2018 | 6.92 Billion USD | -32.58% |
2017 | 6.5 Billion USD | -77.45% |
2016 | 5.27 Billion USD | 66.92% |
2015 | 9.19 Billion USD | -63.54% |
2014 | -1.52 Billion USD | 22.98% |
2013 | -1.98 Billion USD | 73.74% |
2012 | -7.54 Billion USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -403 Million USD | -112.5% |
2024 Q3 | -22 Million USD | 94.54% |
2024 Q1 | -128 Million USD | 3141.51% |
2023 Q4 | 2.01 Billion USD | 277.88% |
2023 Q2 | -225 Million USD | -1000.0% |
2023 Q3 | -1.13 Billion USD | -402.22% |
2023 FY | - USD | 64.51% |
2023 Q1 | 25 Million USD | 104.88% |
2022 Q4 | -512 Million USD | 42.02% |
2022 Q2 | -1.13 Billion USD | -88.26% |
2022 Q1 | -605 Million USD | -136.6% |
2022 FY | - USD | -964.74% |
2022 Q3 | -883 Million USD | 22.48% |
2021 Q3 | -493 Million USD | -3.57% |
2021 FY | - USD | 105.0% |
2021 Q1 | -517 Million USD | -149.47% |
2021 Q4 | 1.65 Billion USD | 435.29% |
2021 Q2 | -476 Million USD | 7.93% |
2020 Q1 | -838 Million USD | -455.08% |
2020 Q3 | -263 Million USD | 94.98% |
2020 Q4 | 1.04 Billion USD | 497.34% |
2020 FY | - USD | -236.46% |
2020 Q2 | -5.24 Billion USD | -525.54% |
2019 Q2 | -763 Million USD | -13.54% |
2019 Q1 | -672 Million USD | -70.99% |
2019 Q4 | 236 Million USD | 124.66% |
2019 FY | - USD | -11.08% |
2019 Q3 | -957 Million USD | -25.43% |
2018 Q4 | -393 Million USD | -257.83% |
2018 Q2 | -499 Million USD | -62.54% |
2018 Q1 | -307 Million USD | -62.43% |
2018 FY | - USD | -32.58% |
2018 Q3 | 249 Million USD | 149.9% |
2017 Q1 | -593 Million USD | -126.72% |
2017 FY | - USD | -77.45% |
2017 Q4 | -189 Million USD | -110.66% |
2017 Q3 | 1.77 Billion USD | 574.06% |
2017 Q2 | -374 Million USD | 36.93% |
2016 Q2 | -191 Million USD | 52.84% |
2016 FY | - USD | 66.92% |
2016 Q4 | 2.21 Billion USD | 707.95% |
2016 Q3 | -365 Million USD | -91.1% |
2016 Q1 | -405 Million USD | -130.13% |
2015 Q3 | -700 Million USD | -22.81% |
2015 FY | - USD | -63.54% |
2015 Q4 | 1.34 Billion USD | 292.0% |
2015 Q2 | -570 Million USD | -41.79% |
2015 Q1 | -402 Million USD | 51.04% |
2014 Q4 | -821 Million USD | 28.98% |
2014 Q3 | -1.15 Billion USD | -167.44% |
2014 FY | - USD | 22.98% |
2014 Q1 | -716 Million USD | -266.13% |
2014 Q2 | 1.71 Billion USD | 339.39% |
2013 Q3 | 1.38 Billion USD | 313.76% |
2013 Q1 | -942 Million USD | 67.47% |
2013 Q4 | 431 Million USD | -68.84% |
2013 FY | - USD | 73.74% |
2013 Q2 | -647 Million USD | 31.32% |
2012 Q4 | -2.89 Billion USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
MetLife, Inc. | -1.26 Billion USD | 11.657% |
Trupanion, Inc. | -20.48 Million USD | -5338.391% |
The Travelers Companies, Inc. | 4.46 Billion USD | 124.927% |